Equasens SA
PAR:EQS

Watchlist Manager
Equasens SA Logo
Equasens SA
PAR:EQS
Watchlist
Price: 41.9 EUR 0.24% Market Closed
Market Cap: 635.6m EUR
Section:
 

Relative Value

The Relative Value of one EQS stock under the Base Case scenario is 56.41 EUR. Compared to the current market price of 41.9 EUR, Equasens SA is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EQS Relative Value
Base Case
56.41 EUR
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
88
vs Industry
41
Median 3Y
3.5
Median 5Y
5
Industry
2.4
Forward
2.6
More Details
17.4
P/E
P/E
Price to Earnings
17.4
vs History
77
vs Industry
35
Median 3Y
18.8
Median 5Y
23.2
Industry
22.9
Forward
16
More Details
12.9
P/OCF
P/OCF
Price to OCF
12.9
vs History
84
vs Industry
33
Median 3Y
14.7
Median 5Y
17.7
Industry
14.7
More Details
39.8
P/FCFE
P/FCFE
Price to FCFE
39.8
vs History
19
vs Industry
21
Median 3Y
27.9
Median 5Y
28.5
Industry
21.4
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
88
vs Industry
33
Median 3Y
3.5
Median 5Y
5.7
Industry
2.3
More Details
2.5
EV/S
EV/S
Enterprise Value to Sales
2.5
vs History
90
vs Industry
42
Median 3Y
3.4
Median 5Y
4.9
Industry
2.6
Forward
2.4
More Details
3.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.7
vs History
92
vs Industry
54
Median 3Y
4.9
Median 5Y
7.2
Industry
5.3
More Details
9.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.2
vs History
92
vs Industry
38
Median 3Y
11.4
Median 5Y
15.2
Industry
12.3
Forward
8.8
More Details
12.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.6
vs History
88
vs Industry
36
Median 3Y
14.7
Median 5Y
19.1
Industry
17.2
Forward
11.7
More Details
11.6
EV/OCF
EV/OCF
Enterprise Value to OCF
11.6
vs History
90
vs Industry
35
Median 3Y
13.6
Median 5Y
17.4
Industry
15
More Details
15.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15.2
vs History
90
vs Industry
26
Median 3Y
19.3
Median 5Y
23.1
Industry
19
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
88
vs Industry
44
Median 3Y
2.3
Median 5Y
4
Industry
1.9
More Details

Multiples Across Competitors

EQS Competitors Multiples
Equasens SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Equasens SA
PAR:EQS
629.8m EUR 2.8 17.4 9.2 12.6
US
Veeva Systems Inc
NYSE:VEEV
36.4B USD 11.7 42.3 32 33.5
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
21.6B AUD 97.2 187.1 129.2 129.2
JP
M3 Inc
TSE:2413
1.4T JPY 4.4 31.5 16 19.7
US
Doximity Inc
NYSE:DOCS
7.6B USD 12.4 29.9 25.9 27.1
US
Waystar Holding Corp
NASDAQ:WAY
5.2B USD 5.1 46.9 15.8 24.7
SE
Sectra AB
STO:SECT B
44.9B SEK 20.4 69.4 -137 -137
CN
Winning Health Technology Group Co Ltd
SZSE:300253
30.8B CNY 14.2 -100.1 -197.8 -197.8
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
292.1B INR 11 60.1 37.4 43.6
US
Heartflow Inc
NASDAQ:HTFL
2.9B USD 0 0 0 0
P/E Multiple
Earnings Growth PEG
FR
Equasens SA
PAR:EQS
Average P/E: 59.7
17.4
17%
1
US
Veeva Systems Inc
NYSE:VEEV
42.3
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
187.1
32%
5.8
JP
M3 Inc
TSE:2413
31.5
16%
2
US
Doximity Inc
NYSE:DOCS
29.9
18%
1.7
US
W
Waystar Holding Corp
NASDAQ:WAY
46.9
N/A N/A
SE
Sectra AB
STO:SECT B
69.4
17%
4.1
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -100.1
92%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
60.1
31%
1.9
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Equasens SA
PAR:EQS
Average EV/EBITDA: 35.9
9.2
12%
0.8
US
Veeva Systems Inc
NYSE:VEEV
32
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
129.2
32%
4
JP
M3 Inc
TSE:2413
16
14%
1.1
US
Doximity Inc
NYSE:DOCS
25.9
23%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
15.8
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -137 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -197.8
36%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.4
24%
1.6
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Equasens SA
PAR:EQS
Average EV/EBIT: 41.7
12.6
13%
1
US
Veeva Systems Inc
NYSE:VEEV
33.5
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
129.2
31%
4.2
JP
M3 Inc
TSE:2413
19.7
N/A N/A
US
Doximity Inc
NYSE:DOCS
27.1
25%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
24.7
58%
0.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -137 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -197.8
47%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.6
26%
1.7
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A

See Also

Summary
EQS intrinsic value, competitors valuation, and company profile.
DCF Valuation
EQS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EQS stock valuation using valuation multiples.
Wall Street Estimates
EQS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EQS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.